May 12, 2025, 17:21

NHMRC: Investigator Grants

Investigator Grants provide leading researchers across all career stages with flexible funding for their salary (if needed) and a significant research support package. These grants support work across biomedical, clinical, public health, and health services research, allowing investigators to pursue innovative directions and collaborations without being limited by predefined project scopes.

Eligibility Criteria:

Open to researchers at all career stages: early, mid, established
Includes clinicians, allied health professionals, public health researchers
Available for both full-time and part-time roles
PhD must be conferred by the application close date
Commitment to gender equity initiatives applies

Funding Details:

Duration: 5 years
Includes: Investigator salary support (if required) + research support package
Funding source: NHMRC (may include partners)
Supports: Biomedical, clinical, public health, and health services research

Deadline:

Applications open: 4 June 2025
Minimum data due: 2 July 2025, 17:00 AEST
Applications close: 30 July 2025, 17:00 AEST
Peer review: September – November 2025
Results notification: February 2026 (embargoed)

Further Information:

Visit GrantConnect or contact NHMRC for application details.

biomedical research cancer clinical research Clinician Scientists Early-career researchers flexible funding gender equity health services research investigator grants mid-career researchers NHMRC OncoDaily Oncology public health research

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot